Vaccinia capping enzyme compositions and methods
US11788074B2 · kind B2 · utility
2Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2021 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Jun 15, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/0705
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.